Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Vir Biotechnology Inc (NASDAQ: VIR) was $5.25 for the day, down -4.20% from the previous closing price of $5.48. In other words, the price has decreased by -$4.20 from its previous closing price. On the day, 0.68 million shares were traded. VIR stock price reached its highest trading level at $5.49 during the session, while it also had its lowest trading level at $5.225.
Ratios:
Our analysis of VIR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.79 and its Current Ratio is at 6.79. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $23 previously.
On September 08, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $23 to $14.
JP Morgan Upgraded its Neutral to Overweight on March 06, 2023, whereas the target price for the stock was revised from $35 to $34.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 15 ’25 when Eisner Mark sold 6,796 shares for $5.47 per share. The transaction valued at 37,162 led to the insider holds 108,204 shares of the business.
Eisner Mark sold 3,586 shares of VIR for $19,629 on Jul 17 ’25. The EVP and Chief Medical Officer now owns 104,618 shares after completing the transaction at $5.47 per share. On Jul 17 ’25, another insider, MARK EISNER, who serves as the Officer of the company, bought 3,586 shares for $5.41 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VIR now has a Market Capitalization of 725749504 and an Enterprise Value of 20182516. For the stock, the TTM Price-to-Sale (P/S) ratio is 34.79 while its Price-to-Book (P/B) ratio in mrq is 0.69. Its current Enterprise Value per Revenue stands at 0.967 whereas that against EBITDA is -0.035.
Stock Price History:
The Beta on a monthly basis for VIR is 1.19, which has changed by -0.48326772 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, VIR has reached a high of $14.45, while it has fallen to a 52-week low of $4.32. The 50-Day Moving Average of the stock is 0.17%, while the 200-Day Moving Average is calculated to be -26.88%.
Shares Statistics:
VIR traded an average of 1.30M shares per day over the past three months and 1004290 shares per day over the past ten days. A total of 138.06M shares are outstanding, with a floating share count of 89.12M. Insiders hold about 35.53% of the company’s shares, while institutions hold 54.45% stake in the company. Shares short for VIR as of 1752537600 were 11294318 with a Short Ratio of 8.69, compared to 1749772800 on 11367540. Therefore, it implies a Short% of Shares Outstanding of 11294318 and a Short% of Float of 13.209999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
